We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+9.05%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$5.12B
AUM Growth
+$72.4M
(+1.4%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
35.15%
Holding
73
New
9
Increased
23
Reduced
23
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$118M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$74.2M |
| 3 |
Visa
V
|
+$71.6M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$61M |
| 5 |
Cadence Design Systems
CDNS
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$101M |
| 2 |
Pentair
PNR
|
+$75M |
| 3 |
Starbucks
SBUX
|
+$56.4M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$54.6M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$48.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 19.91% |
| 2 | Technology | 19.02% |
| 3 | Healthcare | 15.55% |
| 4 | Financials | 14.75% |
| 5 | Consumer Discretionary | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUOT
51
DELISTED
Quotient Technology Inc
QUOT
| $21.4M | 0.42% |
1,208,170
+680,000
| +129% | +$10.1M |
|
52
Eli Lilly
LLY
$1.06T
| $20.7M | 0.4% |
+300,000
| New | +$20.2M |
|
|
OVTI
53
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $20.4M | 0.4% |
784,900
| – | – |
|
54
ON Semiconductor
ON
$18.6B
| $17.7M | 0.35% |
+1,750,000
| New | +$15.4M |
|
55
Applied Materials
AMAT
$419B
| $17.4M | 0.34% |
+700,000
| New | +$15.8M |
|
56
Analog Devices
ADI
$184B
| $13.9M | 0.27% |
+250,000
| New | +$12.8M |
|
57
Best Buy
BBY
$16.9B
| $10.2M | 0.2% |
260,640
-1,275,000
| -83% | -$44.8M |
|
|
WBC
58
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.57M | 0.05% |
24,500
| – | – |
|
59
Immersion
IMMR
$246M
| $1.94M | 0.04% |
205,000
| – | – |
|
|
EJ
60
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $724K | 0.01% |
100,000
-384,650
| -79% | -$3.3M |
|
61
American Express
AXP
$231B
| – | – |
-205,390
| Closed | -$18M |
|
62
Blackstone
BX
$107B
| – | – |
-1,299,225
| Closed | -$40.1M |
|
63
Constellium
CSTM
$3.88B
| – | – |
-1,050,000
| Closed | -$25.8M |
|
|
64
Gilead Sciences
GILD
$162B
| – | – |
-951,010
| Closed | -$101M |
|
65
ServiceNow
NOW
$121B
| – | – |
-2,504,390
| Closed | -$29.4M |
|
|
66
Pentair
PNR
$11.2B
| – | – |
-1,706,022
| Closed | -$75M |
|
67
Qualys
QLYS
$6.29B
| – | – |
-767,398
| Closed | -$20.4M |
|
|
68
Starbucks
SBUX
$120B
| – | – |
-1,496,070
| Closed | -$56.4M |
|
|
TCS
69
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| – | – |
-22,587
| Closed | -$7.38M |
|
|
MXIM
70
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-1,355,000
| Closed | -$41M |
|
|
BID
71
DELISTED
Sotheby's
BID
| – | – |
-350,000
| Closed | -$12.5M |
|
|
CAB
72
DELISTED
Cabela's Inc
CAB
| – | – |
-473,024
| Closed | -$27.9M |
|
|
DANG
73
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| – | – |
-100,000
| Closed | -$1.22M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Alkeon Capital Management held 73 positions worth $5.12B, up 1.4% from $5.05B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Alkeon Capital Management withdrew a net $282M in Q4 2014, closing 13 positions and reducing 23 holdings. Its most notable exit was Gilead Sciences, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Alkeon Capital Management opened a new position in Walgreens Boots Alliance worth $84.6M.
- Alkeon Capital Management's largest Q4 2014 buy was Walgreens Boots Alliance: 1,110,000 shares worth $84.6M.
- Alkeon Capital Management added most to Dollar General in Q4 2014, an estimated $118M increase.
- Alkeon Capital Management's biggest Q4 2014 reduction was BioMarin Pharmaceuticals, cutting an estimated $54.6M.
- Alkeon Capital Management fully exited Gilead Sciences in Q4 2014, selling an estimated $101M.
- Alkeon Capital Management's ten largest holdings make up 35% of its $5.12B portfolio in Q4 2014.
- Alkeon Capital Management opened 9 new positions and closed 13 in Q4 2014.
- Alkeon Capital Management's portfolio value rose 1.4% quarter-over-quarter to $5.12B.
Based on Alkeon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.